This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NovaBay Pharmaceuticals Co-Authors Novel Study Demonstrating Chemical Impact Of N-Chlorotaurine And NVC-422 On Bacterial Toxins

Study Presented at the 52nd ICAAC Validates Aganocide Compound's Mechanism of Action

EMERYVILLE, Calif., Sept. 12, 2012 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE-MKT:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide ® compounds for the local non-systemic treatment and prevention of infections, announces data supporting the mechanism of action for its lead Aganocide compound, NVC-422, against toxins secreted by bacteria such as Escherichia coli ( E. coli). The data was presented at the 52 nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, on September 12, 2012 in a poster that featured a collaborative study with the Innsbruck Medical University.

The poster, titled " N-chlorotaurine, a long-lived endogenous oxidant, inactivates Shiga toxin 2 (Stx2) of enterohemorrhagic E. coli" shows data from a study investigating the chemical impact of Aganocide compounds N-chlorotaurine (NCT), a long-lived oxidant produced by the activation of human white blood cells and known to exert broad-spectrum antimicrobial activity, and its novel analog with long-term solution stability, NVC-422, on Shiga toxin 2 (Stx2), a toxin secreted by E. coli. The study provided evidence that 5.5 mM of NCT or NVC-422 oxidizes and inactivates the toxin Stx2, therefore concluding that long-lived oxidants, such as NCT, may act as powerful tools of innate immunity against soluble toxins secreted by common bacteria.

Dmitri Debabov, Ph.D., Director of Cell Biology and Microbiology at NovaBay and co-author of the study, stated, "This study shows the chemical impact of Aganocides and proves their ability to neutralize bacterial toxins. With the discovery of NovaBay's Aganocide NVC-422, we've identified a novel analog of NCT with a higher long-term solution stability, rapid antimicrobial activity and activity against bacterial toxins. Therefore, we believe this data provides further evidence that NVC-422 is capable of therapeutic success as a topical anti-infective."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs